Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open‐label, 3‐arm parallel comparative, exploratory study

This study investigated the safety and efficacy of the sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor luseogliflozin with differing carbohydrate intakes in Japanese individuals with type 2 diabetes (T2D). Participants were randomly assigned to 3 carbohydrate‐adjusted meals for 14 days (days 1‐14;...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Obes Metab
Main Authors: Yabe, Daisuke, Iwasaki, Masahiro, Kuwata, Hitoshi, Haraguchi, Takuya, Hamamoto, Yoshiyuki, Kurose, Takeshi, Sumita, Kiminobu, Yamazato, Hitoshi, Kanada, Shigeto, Seino, Yutaka
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2017
Assuntos:
Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412941/
https://ncbi.nlm.nih.gov/pubmed/27990776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12848
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares